Abstract: A compound having the general formula (I) R1—NH—CH[(CH2)n—NH—C(NH)—NH2]-CO—R2-A-R4; a pharmaceutical composition comprising the compound and use of the compound for the manufacturing of a medicament for the treatment of a disease such as a microbial disease and/or proliferation/stimulation of eukaryotic cells is described.
Type:
Grant
Filed:
May 4, 2007
Date of Patent:
January 17, 2012
Assignee:
Neobiotics AB
Inventors:
Anders Grubb, Aftab Jasir, Claes Schalén, Franciszek Kasprzykowski, Regina Kasprzykowska
Abstract: The invention relates to compositions comprising a compound based on the general formula (I) R1-Arg-R2—NH—CH(R3)—CH2—NH—R4??(I) The composition may be used to eliminate and/or reduce microorganisms such as bacteria, viruses, fungi and protozoa.
Type:
Application
Filed:
March 8, 2010
Publication date:
September 30, 2010
Applicant:
Neobiotics AB
Inventors:
Anders Grubb, Aftab Jasir, Claes Schalén, Franciszek Kasprzykowski, Regina Kasprzykowska
Abstract: The invention relates to compositions comprising a compound based on the general formula (I) R1-Arg-R2—NH—CH(R3)—CH2—NH—R4 ??(I) and a carrier, diluent or an excipient.
Type:
Grant
Filed:
November 10, 2005
Date of Patent:
April 6, 2010
Assignee:
Neobiotics AB
Inventors:
Anders Grubb, Aftab Jasir, Claes Schalén, Franciszek Kasprzykowski, Regina Kasprzykowska
Abstract: The invention relates to compositions comprising a compound based on the general formula (I) R1-Arg-R2—NH—CH(R3)—CH2—NH—R4 ??(I) The composition may be used to eliminate and/or reduce microorganisms such as bacteria, viruses, fungi and protozoa.
Type:
Application
Filed:
November 10, 2005
Publication date:
June 1, 2006
Applicant:
Neobiotics AB
Inventors:
Anders Grubb, Aftab Jasir, Claes Schalen, Franciszek Kasprzykowski, Regina Kasprzykowska